The global Cryopreservation Equipment Market, by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 4.318.1 million in 2017 and is projected to exhibit a CAGR of 13.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.
Cryopreservation equipment are used to cryopreserve biological samples by preventing the dehydration and formation of intracellular ice crystals. Cryopreservation equipment includes controlled rate freezers, freezing racks and holders, cryogenic incubators, cryopreservation loading chambers and tanks, thermocouple sensor for temperate detection, storage sample chambers, vapor and liquid phase storage, and canister and cane systems.
Moreover, the increasing demand for fertility treatment such as in-vitro fertilization (IVF) treatment and therapies for women and higher effectiveness of frozen embryos in the IVF procedures are expected to drive growth of the cryopreservation equipment market. For instance, research findings published in the TIME Health, in January 2018, conducted a study including 3,000 women in Vietnam who underwent IVF procedures, and were randomly assigned to receive frozen or fresh embryo. 36% of the women implanted with frozen embryo had live births, as compared to the 31% of them who were implanted with fresh embryo. Additionally, researchers at the Penn State College of Medicine, conducted a five-week study on women suffering from polycystic ovarian syndrome (PCOS). Those who received frozen embryos during the in-vitro fertilization recorded safer and more successful pregnancies than those who received fresh embryos. Frozen embryos lowered the risk of ovarian hyperstimulation syndrome by 7.1% to 10.3%, as compared to using fresh embryos. Freezing embryos offers couples the advantage of genetic testing, to reduce the chance of the genetic diseases prior implantation of the embryo.
The umbilical cord blood (UCB) stem cells is non-invasive alternative source of hematopoietic stem cells to treat a variety of blood and bone marrow diseases, blood cancers, metabolic disorders, and immune deficiencies. Umbilical cord blood is required to be collected at the time of birth and be cryopreserved for future applications. However, low awareness regarding the benefits of preserving umbilical cord banking (UCB), limits its application in the long run, thereby limiting growth of the cryopreservation equipment market. A study published as the Banking Umbilical Cord Blood (UCB) Stem Cells: awareness, attitude and expectations of donor, in the National Center for Biotechnology Information (NCBI), in May 2016, showed that pregnant women in emerging economies show lower awareness regarding UCB. The study was conducted on 300 women, among whom only 26.5% were aware of UCB, 31% were aware of the private cord blood banking, while only 16% were aware of public cord blood banking.
Browse 43 Market Data Tables and 48 Figures spread through 180 Pages and in-depth TOC on “Cryopreservation Equipment Market by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)” - Global Forecast to 2025
To know the latest trends and insights prevalent in the cryopreservation equipment market, click the link below:
Key Takeaways of the Cryopreservation Equipment Market:
Some of the key players operating in the cryopreservation equipment market are Thermo Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory Equipment Development Co., Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.